GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
92 hedge funds and large institutions have $975M invested in GW Pharmaceuticals Plc American Depositary Shares in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 25 increasing their positions, 25 reducing their positions, and 18 closing their positions.
78% more capital invested
Capital invested by funds: $548M → $975M (+$427M)
28% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 18
6% more funds holding
Funds holding: 87 → 92 (+5)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 25
27% less call options, than puts
Call options by funds: $25.6M | Put options by funds: $34.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$80.9M |
| 2 |
Bank of New York Mellon
New York
|
+$47.6M |
| 3 |
DM
Deerfield Management
New York
|
+$29.5M |
| 4 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
+$18.5M |
| 5 |
O
OrbiMed
New York
|
+$16.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPM
Chesapeake Partners Management
Baltimore,
Maryland
|
-$27.3M |
| 2 |
PP
Prudential plc
London, England,
United Kingdom
|
-$23.8M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.75M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$4.34M |
| 5 |
Morgan Stanley
New York
|
-$4.3M |
GWPH Hedge Fund Activity: Q1 2015 in Review
92 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q1 2015, worth a combined $975M — up 78% from $548M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new GWPH positions and 18 closed out — a net gain of 5 holders — while 25 added to existing stakes and 25 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $80.9M. The largest seller was Chesapeake Partners Management, cutting an estimated $27.3M.
- 92 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q1 2015, up from 87 in Q4 2014.
- Funds reported $975M of GW Pharmaceuticals Plc American Depositary Shares stock for Q1 2015, up 78% quarter-over-quarter.
- 23 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q1 2015 and 18 closed out, a net change of +5 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q1 2015 was Fidelity Investments, an estimated $80.9M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q1 2015 was Chesapeake Partners Management, an estimated $27.3M sold.
Based on aggregated 13F filings for Q1 2015.